Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011;128:3–22.e6.

Article  PubMed  Google Scholar 

Straumann A, Katzka DA. Diagnosis and treatment of eosinophilic esophagitis. Gastroenterology 2018;154:346–59.

Article  PubMed  Google Scholar 

Mukkada V, Falk GW, Eichinger CS, et al. Health-related quality of life and costs associated with eosinophilic esophagitis: a systematic review. Clin Gastroenterol Hepatol 2018;16(4):495.e8-503.e8.

Article  PubMed  Google Scholar 

Stern E, Taft T, Zalewski A, et al. Prospective assessment of disease-specific quality of life in adults with eosinophilic esophagitis. Dis Esophagus 2018;31(4).

Attwood SEA, Smyrk TC, Demeester TC, et al. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38:109–116.

Article  CAS  PubMed  Google Scholar 

Furuta GT, Katzka DA. Eosinophilic esophagitis. N Engl J Med 2015; 373:1640–1648.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arias Á, Pérez-Martínez I, Tenías JM, et al. Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2016;43(1):3–15

Article  CAS  PubMed  Google Scholar 

Gandhi NA, Pirozzi G, Graham NMH. Commonality of the IL-4/IL-13 pathway in atopic diseases. Expert Rev Clin Immunol 2017;13:425–37.

Article  CAS  PubMed  Google Scholar 

Hirano I, Aceves SS. Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis. Gastroenterol Clin North Am 2014;43:297–316.

Article  PubMed  PubMed Central  Google Scholar 

Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology 2013;145:1230–1236.

Article  PubMed  Google Scholar 

Mukkada V, Falk GW, Eichinger CS, et al. Health-related quality of life and costs associated with eosinophilic esophagitis: a systematic review. Clin Gastroenterol Hepatol 2018;16(4):495.e8-503.e8.

Article  PubMed  Google Scholar 

Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007;133:1342–63.

Article  CAS  PubMed  Google Scholar 

Brown-Whitehorn TF, Spergel JM. The link between allergies and eosinophilic esophagitis: implications for management strategies. Expert Rev Clin Immunol 2010;6:101–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med 2004;351:940–1.

Article  CAS  PubMed  Google Scholar 

Spergel JM, Rothenberg ME, Collins MH, et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129(2):456 – 63,463.e1-3.

Article  CAS  PubMed  Google Scholar 

Slack IF, Schwartz JT, Mukkada VA, et al. Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine. Current Allergy and Asthma Reports 2020; 20: 30

Article  PubMed  PubMed Central  Google Scholar 

Collins MH, Martin LJ, Alexander ES, et al. Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring. Dis Esophagus. 2017;30(3):1–8.

CAS  PubMed  Google Scholar 

Hirano I, Moy N, Heckman MG, et al. Endoscopic assessment of the esophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut 2013; 62:489–495.

Article  PubMed  Google Scholar 

Dutta P, Shah-Riar P, Bushra SS, et al. Recent Trends in the Management of Eosinophilic Esophagitis: A Systematic Review. Cureus. 2023;15(8):e43221.

PubMed  PubMed Central  Google Scholar 

Hirano I, Chan ES, Rank MA, et al. AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters clinical guidelines for the management of eosinophilic esophagitis. Gastroenterology 2020;158(6):1776–86.

Article  PubMed  Google Scholar 

Rank MA, Sharaf RN, Furuta GT, et al. Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Gastroenterology. 2020;158(6):1789–1810.e15.

Article  CAS  PubMed  Google Scholar 

Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology 2018;154(2):319. e3-332.e3.

Article  PubMed  Google Scholar 

Rothenberg ME, Wen T, Greenberg A, et al. Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2014;135:500–507.

Article  PubMed  Google Scholar 

Wolf WA, Cotton CC, Green DJ, et al. Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients. Clin Gastroenterol Hepatol. 2015;13:452–458.

Article  PubMed  Google Scholar 

Dellon ES. Management of refractory eosinophilic esophagitis. Nat Rev Gastroenterol Hepatol 2017; 14:479–490.

Article  PubMed  PubMed Central  Google Scholar 

Eschenbacher W, Straesser M, Knoeddler A, et al. Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis. Immunol Allergy Clin North Am. 2020;40(4):539–547.

Article  PubMed  PubMed Central  Google Scholar 

Kardas G, Panek M, Kuna P, et al. Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives. Front Immunol. 2022;13:983852.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Franciosi JP, Gordon M, Sinopoulou V, et al. Medical treatment of eosinophilic esophagitis. Cochrane Database Syst Rev. 2023;7(7): CD004065.

PubMed  Google Scholar 

Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021:372.

Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: l4898.

Article  PubMed  Google Scholar 

Schunemann HJ, Brennan S, Akl EA, et al. The development methods of official GRADE articles and requirements for claiming the use of GRADE- a statement by the GRADE Guidance Group. J Clin Epidemiol. 2023;159:79–84.

Article  PubMed  Google Scholar 

Higgins JPT, Eldridge S, Li T. Chapter 23: Including variants on randomized trials. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org/handbook.

Higgins JPT, Li T, Deeks JJ (editors). Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.

Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135.

Article  PubMed  PubMed Central  Google Scholar 

Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–1805.

Article  PubMed  Google Scholar 

Dellon ES, Rothenberg ME, Collins MH, et al. Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis. N Engl J Med. 2022;387(25):2317–2330.

Article  CAS  PubMed  Google Scholar 

Hirano I, Dellon ES, Hamilton JD, et al. Efficacy of Dupilumab in a Phase 2 randomized trial of adults with active eosinophilic esophagitis. Gastroenterology 2020;158(1):111–122.e10.

Article  CAS  PubMed  Google Scholar 

Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial. Gut. 2010;59(1):21–30.

Article  CAS  PubMed  Google Scholar 

Clayton F, Fang JC, Gleich GJ, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 2014;147(3):602–9.

Article  CAS  PubMed  Google Scholar 

Hirano I, Collins MH, Assouline-Dayan Y, et al. RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis. Gastroenterology. 2019;156(3):592–603.e10.

Article  CAS  PubMed  Google Scholar 

Ishimura N, Okimoto E, Shibagaki K, et al. Similarity and difference in the characteristics of eosinophilic esophagitis between Western countries and Japan. Dig. Endosc. 2021; 33:708–719.

Article  PubMed  Google Scholar 

Arias Á, Lucendo AJ. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice. Expert Rev.